Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning

Y Shoenfeld - Autoimmunity reviews, 2020 - pmc.ncbi.nlm.nih.gov
The 2020 coronavirus epidemic is characterized by high infectious rates and relatively high
mortality, especially among the elderly over the age of 80. In this issue we published two …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

EULAR recommendations for the management of antiphospholipid syndrome in adults

MG Tektonidou, L Andreoli, M Limper, Z Amoura… - Annals of the rheumatic …, 2019 - Elsevier
The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …

Thrombophilia testing: a British Society for Haematology guideline

DJ Arachchillage, L Mackillop… - British journal of …, 2022 - pmc.ncbi.nlm.nih.gov
Guidelines Committee and the sounding board of BSH. It was also placed on the members
section of the BSH website for comment. It has also been reviewed by Royal College of …

Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry

I Rodríguez-Pintó, M Moitinho, I Santacreu… - Autoimmunity …, 2016 - Elsevier
Objective To analyze the clinical and immunologic manifestations of patients with
catastrophic antiphospholipid syndrome (CAPS) from the “CAPS Registry”. Methods The …

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review

R Cervera, I Rodríguez-Pintó, G Espinosa - Journal of autoimmunity, 2018 - Elsevier
The catastrophic antiphospholipid syndrome (CAPS) is a life-threating variant of the
antiphospholipid syndrome characterized by the development of multiple thrombosis in a …

The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th international congress on antiphospholipid antibodies technical task force …

MM Abreu, A Danowski, DG Wahl, MC Amigo… - Autoimmunity …, 2015 - Elsevier
The purpose of this task force was to critically analyze nine non-criteria manifestations of
APS to support their inclusion as APS classification criteria. The Task Force Members …

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

B López-Benjume, I Rodríguez-Pintó, MC Amigo… - Autoimmunity …, 2022 - Elsevier
Objectives To describe the real-world experience of eculizumab use in patients with
catastrophic antiphospholipid syndrome (CAPS) according to the information provided by …